Clinton Yam

8PUBLICATIONS

85CO-AUTHORS

Cancer therapy (excl. chemotherapy and radiation therapy)Cancer cell biologyMolecular targetsChemotherapy

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (8)

Sort by Publication Date:

|May 13, 2026

Ecotypes of triple-negative breast cancer in response to chemotherapy.

|May 04, 2026

Characteristics and Clinical Outcomes of BRCA Germline Mutation Carriers with Advanced Breast Cancer Treated with PARP (Poly ADP-Ribose Polymerase) Inhibitors: A Single-Institution Experience.

|Jan 21, 2026

Sacituzumab Govitecan plus Pembrolizumab for Advanced Triple-Negative Breast Cancer.

Sara M Tolaney, Evandro de Azambuja, Kevin Kalinsky

|Nov 20, 2025

Early tumor volume reduction by breast DCE MRI predicts pathologic complete response to neoadjuvant therapy in triple negative breast cancer.

Mary S Guirguis, Beatriz E Adrada, Clinton Yam

|Aug 13, 2025

An Annotated Biobank of Triple-Negative Breast Cancer Patient-Derived Xenografts Features Treatment-Naïve and Longitudinal Samples during Neoadjuvant Chemotherapy.

Amanda L Rinkenbaugh, Yuan Qi, Shirong Cai

|Dec 31, 2024

NOS inhibition sensitizes metaplastic breast cancer to PI3K inhibition and taxane therapy via c-JUN repression.

Tejaswini Reddy, Akshjot Puri, Liliana Guzman-Rojas

Pageof 2

Frequent Collaborators

Debu Tripathy

Stacy L Moulder

Jeffrey T Chang

Lei Huo

Gaiane M Rauch

Bora Lim

Vicente Valero

Alastair M Thompson

Xiaoping Wang

David L Ramirez

Frequent Collaborators

Debu Tripathy

Stacy L Moulder

Jeffrey T Chang

Lei Huo